Bio-Rad Laboratories, Inc. Share Price Today: Live Updates & Key Insights

Bio-Rad Laboratories, Inc. share price today is $264.49, up -0.19%. The stock opened at $265 against the previous close of $265, with an intraday high of $267.73 and low of $262.42.

Bio-Rad Laboratories, Inc. Share Price Chart

Bio-Rad Laboratories, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Bio-Rad Laboratories, Inc. Share Price Performance

$264.49 -0.0019(-0.19%) BIO at 23 Mar 2026 12:13 PM Medical Devices
Lowest Today 262.42
Highest Today 267.73
Today’s Open 265
Prev. Close 265
52 Week High 343.12
52 Week Low 211.43
Day’s Range: Low 262.42 High 267.73
52-Week Range: Low 211.43 High 343.12
1 day return -
1 Week return +1.24
1 month return -1.57
3 month return -13.32
6 month return -6.82
1 year return +2.93
3 year return -43.32
5 year return -54.44
10 year return -

Bio-Rad Laboratories, Inc. Institutional Holdings

Arnhold & S. Bleichroeder Advisers, LLC 9.52

First Eagle Global A 6.96

Vanguard Group Inc 6.57

BlackRock Inc 6.28

UBS: Global Equity 4.70

Dimensional Fund Advisors, Inc. 3.99

Ariel Investments, LLC 2.83

Earnest Partners LLC 2.24

iShares Core S&P Mid-Cap ETF 2.17

Vanguard Total Stock Mkt Idx Inv 2.17

State Street Corp 2.12

Veritas Asset Management LLP 2.01

Capital Research Global Investors 1.83

Bank of America Corp 1.70

American Funds SMALLCAP World A 1.63

Vanguard Small Cap Index 1.56

First Pacific Advisors, LP 1.49

Massachusetts Financial Services Company 1.48

UBS Asset Mgmt Americas Inc 1.47

Geode Capital Management, LLC 1.25

Ariel Fund Investor 1.14

DFA US Small Cap Value I 1.08

SEI Investments Co 1.05

MFS Mid Cap Growth A 1.03

MFS Mid Cap Growth Equity 1.03

Vanguard Small Cap Value Index Inv 1.00

Parnassus Investments LLC 0.93

Parnassus Value Equity Fund Composite 0.92

Parnassus Value Equity Investor 0.92

EARNEST Partners Smid Cap Core Founders 0.92

Boston Partners Global Investors, Inc 0.92

FPA Contrarian Value 0.90

FPA Crescent 0.90

First Eagle Amundi International AU-C 0.90

Fuller & Thaler Asset Management Inc 0.88

Mawer Investment Management Ltd 0.87

UBS Group AG 0.85

Vanguard Institutional Extnd Mkt Idx Tr 0.73

JHancock Disciplined Value Mid Cap I 0.67

FullerThaler Behavioral Small-Cap Growth 0.65

Bio-Rad Laboratories, Inc. Market Status

Strong Buy: 2

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

Bio-Rad Laboratories, Inc. Fundamentals

Market Cap 7138.69 M

PB Ratio 0.9596

PE Ratio 9.514

Enterprise Value 7015.84 M

Total Assets 10576.50 M

Volume 462439

Bio-Rad Laboratories, Inc. Company Financials

Annual Revenue FY25:2583200000 2583.2M, FY24:2566500000 2566.5M, FY23:2720366000 2720.4M, FY22:2802249000 2802.2M, FY21:2922545000 2922.5M

Annual Profit FY25:1343600000 1343.6M, FY24:1378900000 1378.9M, FY23:1457680000 1457.7M, FY22:1567330000 1567.3M, FY21:1640661000 1640.7M

Annual Net worth FY25:759900000 759.9M, FY24:-1844200000 -1844.2M, FY23:-159298000 -159.3M, FY22:-3627535000 -3627.5M, FY21:4245902000 4245.9M

Quarterly Revenue Q4/2025:693200000 693.2M, Q3/2025:653000000 653.0M, Q2/2025:651600000 651.6M, Q1/2025:585400000 585.4M, Q4/2024:667500000 667.5M

Quarterly Profit Q4/2025:345200000 345.2M, Q3/2025:343400000 343.4M, Q2/2025:345300000 345.3M, Q1/2025:306000000 306.0M, Q4/2024:342000000 342.0M

Quarterly Net worth Q4/2025:720000000 720.0M, Q3/2025:-341900000 -341.9M, Q2/2025:317800000 317.8M, Q1/2025:64000000 64.0M, Q4/2024:-715800000 -715.8M

About Bio-Rad Laboratories, Inc. & investment objective

Company Information Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Organisation Medical Devices

Employees 7450

Industry Medical Devices

CEO Mr. Norman D. Schwartz

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Bio-Rad Laboratories, Inc. FAQs

What is the share price of Bio-Rad Laboratories, Inc. today?

The current share price of Bio-Rad Laboratories, Inc. is $264.49.

Can I buy Bio-Rad Laboratories, Inc. shares in India?

Yes, Indian investors can buy Bio-Rad Laboratories, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Bio-Rad Laboratories, Inc. shares in India?

You can easily invest in Bio-Rad Laboratories, Inc. shares from India by:

Can I buy fractional shares of Bio-Rad Laboratories, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. has a market cap of $7138.69 M.

In which sector does Bio-Rad Laboratories, Inc. belong?

Bio-Rad Laboratories, Inc. operates in the Medical Devices sector.

What documents are required to invest in Bio-Rad Laboratories, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Bio-Rad Laboratories, Inc.?

The PE ratio of Bio-Rad Laboratories, Inc. is 9.51 and the PB ratio is 0.96.